跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ MORPHINE SR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ MORPHINE SR
Authorized
STANDARD
SANDOZ MORPHINE SR
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b42bc13ba69d4065
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
b42bc13ba69d4065
Drug Approval Canada Name
SANDOZ MORPHINE SR
Product Name
SANDOZ MORPHINE SR
Status
Marketed
Status Date
2018-12-19
Original Market Date
2018-12-19
Din
02478897
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA01 MORPHINE
Atc Name
n 02 aa 01
Aig Number
0104545013
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
MORPHINE SULFATE
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b42bc13ba69d4065
Type
Standard
Back to Health Canada Approvals